According to foreign media reports，stake sports betting appAbbott Pharmaceutical (ABT) announced Wednesday，It has reached an authorized agreement worth $ 575 million with the NBIX (NBIX)。Related authorization is a drug that treats pain caused by endometriosis。According to the agreement，Abbott Pharmaceutical will pay 75 million US dollars，Used to fund development activities，and at the beginning of the start of mass production，Pay to up to 500 million US dollars as a license fee。At present, this drug has completed the research and development of the IIB stage。   
    Endometriosis is related to a variety of common pathological symptoms，Including pain during menstruation，Chronic pelvic pain and infertility。